Factors Impacting Overall and Event-Free Survival following Post-Chimeric Antigen Receptor T Cell Consolidative Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Factors Impacting Overall and Event-Free Survival following Post-Chimeric Antigen Receptor T Cell Consolidative Hematopoietic Stem Cell Transplantation

Published:2022-01 Issue:1 Volume:28 Page:31.e1-31.e9
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Molina John C.^ORCID,Steinberg Seth M.^ORCID,Yates Bonnie,Lee Daniel W.^ORCID,Little Lauren,Mackall Crystal L.,Shalabi Haneen,Shah Nirali N.^ORCID

Funder

National Cancer Institute

NIH Clinical Center

National Institutes of Health

Institut National Du Cancer

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference50 articles.

1. Prognostic significance of minimal residual disease in high-risk B-ALL: a report from Children's Oncology Group study AALL0232;Borowitz;Blood,2015

2. Role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review;Oliansky;Biol Blood Marrow Transplant,2012

3. Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults;Gardner;Blood,2017

4. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia;Maude;N Engl J Med,2018

5. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia;Park;N Engl J Med,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting relapse in acute lymphoblastic leukemia;Leukemia & Lymphoma;2024-08-31

2. The road more or less traveled- Examining the role of consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T cell therapy in B-cell ALL;Seminars in Hematology;2024-08

3. INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia;Transplantation and Cellular Therapy;2023-11

4. Optimizing CAR‐T cell therapy in adults with B‐cell acute lymphoblastic leukemia;European Journal of Haematology;2023-09-29

5. Adverse events and efficacy of second‐round CAR‐T cell therapy in relapsed pediatric B‐ALL;European Journal of Haematology;2023-08-30